(Q46522736)

English

Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper

scientific article published in May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

1 reference

based on heuristic

inferred from title

author name string

Boris Gorovits

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Stephen C Alley

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Sanela Bilic

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Brian Booth

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Surinder Kaur

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Phillip Oldfield

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Shobha Purushothama

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Chetana Rao

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Stacy Shord

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Patricia Siguenza

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

997-1006

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Antibody conjugate therapeutics: challenges and potential

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Renaissance of cancer therapeutic antibodies

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Therapeutic antibodies: successes, limitations and hopes for the future

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Pharmacokinetic considerations for antibody drug conjugates

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Tunable degradation of maleimide-thiol adducts in reducing environments

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Contribution of linker stability to the activities of anticancer immunoconjugates

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Challenges in developing bioanalytical assays for characterization of antibody-drug conjugates

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Drug metabolites in safety testing

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry

1 reference

https://api.crossref.org/works/10.4155%2FBIO.13.38

21 January 2018

Identifiers

10.4155/BIO.13.38

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/23641692

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46522736&oldid=2115836086"